PAX9 inhibitors are a specialized class of chemical compounds designed to specifically target and inhibit the activity of the PAX9 protein, which stands for paired box 9. PAX9 is a transcription factor that belongs to the paired box (PAX) family of proteins, which play critical roles in regulating gene expression during embryonic development. This protein is essential for the development of various tissues and organs, including the formation of teeth, where it regulates the expression of genes involved in the growth and differentiation of dental tissues. By binding to specific DNA sequences, PAX9 influences the transcriptional activity of target genes, thereby orchestrating complex developmental processes.
Structurally, PAX9 inhibitors can encompass a wide range of molecules, including small organic compounds, peptides, or larger biomolecules engineered to interact specifically with the DNA-binding domain or other functional regions of the PAX9 protein. These inhibitors typically function by blocking the ability of PAX9 to bind to its target DNA sequences, thereby preventing it from activating or repressing the transcription of its target genes. By inhibiting PAX9, these compounds can disrupt the regulatory networks controlled by this transcription factor, leading to alterations in the expression of genes critical for development. The study of PAX9 inhibitors is crucial for understanding the molecular mechanisms by which PAX9 regulates gene expression and the broader implications of its activity on developmental processes. Research into these inhibitors provides valuable insights into the role of transcription factors in cellular differentiation, tissue formation, and the maintenance of developmental programs. By exploring the effects of PAX9 inhibition, scientists can gain a deeper understanding of the intricate regulatory networks that govern development and the importance of precise gene regulation in maintaining proper tissue and organ formation.
VER TAMBIÉN ....
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | ¥1117.00 ¥3779.00 ¥9432.00 ¥23681.00 | 47 | |
Un inhibidor de la γ-secretasa que podría afectar a la función de Paired Box (PAX) a través de la vía de señalización Notch, afectando al desarrollo neuronal. | ||||||
Chetomin | 1403-36-7 | sc-202535 sc-202535A | 1 mg 5 mg | ¥2053.00 ¥7457.00 | 10 | |
Un metabolito fúngico que puede inhibir la activación transcripcional mediada por Paired Box (PAX) al interactuar con su dominio de unión al ADN. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | ¥361.00 ¥846.00 ¥1331.00 | 14 | |
Un modulador del receptor de esfingosina-1-fosfato que podría afectar a la expresión de Paired Box (PAX) y a las vías de señalización implicadas en el desarrollo neural. | ||||||
UNC0631 | 1320288-19-4 | sc-397011 | 5 mg | ¥1681.00 | ||
Un potente inhibidor de la histona metiltransferasa G9a que podría afectar a la regulación epigenética de la expresión de Paired Box (PAX). | ||||||
Cryptotanshinone | 35825-57-1 | sc-280649 | 10 mg | ¥1320.00 | 1 | |
Un compuesto natural con posibles efectos inhibidores sobre la expresión de Paired Box (PAX), que podría afectar al desarrollo neuronal. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | ¥1444.00 ¥5697.00 | 2 | |
Un inhibidor de las metiltransferasas de ADN que podría afectar a la expresión de Paired Box (PAX) y a la regulación epigenética en células neuronales. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | ¥1726.00 | 5 | |
Aunque no es un inhibidor directo de Paired Box (PAX), ibrutinib es un inhibidor de la tirosina quinasa de Bruton (BTK) que afecta a las vías de señalización de las células B, lo que indirectamente afecta a la actividad de Paired Box (PAX). | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | ¥553.00 ¥4140.00 ¥22902.00 | 18 | |
Aunque no es un inhibidor directo de Paired Box (PAX), la lenalidomida puede afectar a la función y supervivencia de las células B, influyendo potencialmente en la actividad de Paired Box (PAX). | ||||||